Innophos Holdings Inc. (IPHS) To Go Ex-Dividend on November 16th
Innophos Holdings Inc. (NASDAQ:IPHS) declared a quarterly dividend on Monday, October 31st. Investors of record on Friday, November 18th will be given a dividend of 0.48 per share on Friday, December 2nd. This represents a $1.92 dividend on an annualized basis and a yield of 3.84%. The ex-dividend date of this dividend is Wednesday, November 16th.
Innophos Holdings (NASDAQ:IPHS) opened at 50.06 on Friday. The stock has a market capitalization of $965.86 million, a price-to-earnings ratio of 29.07 and a beta of 0.65. Innophos Holdings has a 12-month low of $22.06 and a 12-month high of $50.86. The company has a 50-day moving average price of $41.70 and a 200-day moving average price of $40.66.
Innophos Holdings (NASDAQ:IPHS) last posted its earnings results on Thursday, October 27th. The company reported $0.75 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.66 by $0.09. Innophos Holdings had a return on equity of 10.36% and a net margin of 4.66%. The firm had revenue of $186.03 million for the quarter, compared to analyst estimates of $180.04 million. During the same quarter in the prior year, the company earned $0.66 EPS. Innophos Holdings’s revenue was down 6.8% on a year-over-year basis. On average, equities research analysts forecast that Innophos Holdings will post $2.64 earnings per share for the current year.
IPHS has been the topic of a number of recent research reports. TheStreet raised Innophos Holdings from a “hold” rating to a “buy” rating in a research note on Friday, November 4th. Sidoti initiated coverage on Innophos Holdings in a report on Thursday, October 20th. They issued a “buy” rating for the company. Finally, Zacks Investment Research downgraded Innophos Holdings from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 12th.
In other Innophos Holdings news, Director Robert J. Zatta purchased 1,000 shares of the business’s stock in a transaction on Friday, September 9th. The stock was bought at an average cost of $40.31 per share, for a total transaction of $40,310.00. Following the acquisition, the director now owns 6,351 shares of the company’s stock, valued at approximately $256,008.81. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.00% of the stock is owned by company insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. increased its position in shares of Innophos Holdings by 9.0% in the second quarter. Vanguard Group Inc. now owns 1,560,041 shares of the company’s stock valued at $65,849,000 after buying an additional 128,555 shares during the period. BlackRock Fund Advisors increased its stake in Innophos Holdings by 3.7% in the second quarter. BlackRock Fund Advisors now owns 1,259,752 shares of the company’s stock worth $53,174,000 after buying an additional 44,442 shares during the last quarter. BlackRock Institutional Trust Company N.A. increased its stake in Innophos Holdings by 3.1% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 495,853 shares of the company’s stock worth $19,353,000 after buying an additional 14,782 shares during the last quarter. Northern Trust Corp increased its stake in Innophos Holdings by 5.2% in the third quarter. Northern Trust Corp now owns 433,458 shares of the company’s stock worth $16,918,000 after buying an additional 21,485 shares during the last quarter. Finally, Parametric Portfolio Associates LLC increased its stake in Innophos Holdings by 11.2% in the second quarter. Parametric Portfolio Associates LLC now owns 155,729 shares of the company’s stock worth $6,573,000 after buying an additional 15,739 shares during the last quarter. Institutional investors own 93.42% of the company’s stock.
Innophos Holdings Company Profile
Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. Its segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and GTSP & Other.
Receive News & Stock Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related stocks with our FREE daily email newsletter.